Mouse leukemia: therapy with monoclonal antibodies against a thymus differentiation antigen

Science
I D BernsteinR C Nowinski

Abstract

Monoclonal antibodies against a thymus cell differentiation antigen (Thy-1.1) were effective in the therapy of a transplanted mouse leukemia. Passive immunization resulted in high titers of cytotoxic antibody in the serum of treated mice and the suppression of metastatic tumor cells. The tumor-suppressive effects of the monoclonal antibodies were amplified by the administration of exogenous complement. This combined antibody and complement therapy resulted in the cure of leukemia in a significant proportion of the treated animals.

References

Sep 1, 1977·Virology·R C NowinskiR Pickering
Jul 1, 1976·European Journal of Immunology·G Köhler, C Milstein
Mar 1, 1977·Journal of the National Cancer Institute·T GhoseJ Tal
Sep 1, 1976·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·G J O'Neill
Jan 1, 1976·Annals of the New York Academy of Sciences·A E ReifP J Smith
Jul 15, 1973·International Journal of Cancer. Journal International Du Cancer·S C Bansal, H O Sjögren
Oct 1, 1973·The Journal of Experimental Medicine·R L KasselW D Hardy
Jan 1, 1967·Proceedings of the Society for Experimental Biology and Medicine·L J OldG Geering
Nov 1, 1964·The Journal of Experimental Medicine·B CINADERA C WARDLAW

❮ Previous
Next ❯

Citations

Jan 1, 1983·Cancer Metastasis Reviews·L Olsson
Jan 1, 1986·Journal of Cancer Research and Clinical Oncology·D StavrouP Mehraein
Jan 1, 1982·Springer Seminars in Immunopathology·J W Goding
Dec 1, 1981·In Vitro·R H Kennett
May 31, 2007·Journal of Cancer Research and Clinical Oncology·Despoina OikonomouJakob R Izbicki
Jun 1, 1985·European Journal of Obstetrics, Gynecology, and Reproductive Biology·H Haisma, J Hilgers
Jan 1, 1983·Pharmacology & Therapeutics·W E Magee, S S Ristow
Aug 1, 1984·European Journal of Cancer & Clinical Oncology·M KatanoR F Irie
Jan 1, 1984·Critical Reviews in Oncology/hematology·R V Smalley, R K Oldham
Mar 16, 2013·Proceedings of the National Academy of Sciences of the United States of America·Nicole M OkeleyPeter D Senter
Aug 1, 1982·Proceedings of the National Academy of Sciences of the United States of America·D Herlyn, H Koprowski
Jan 1, 1983·Proceedings of the National Academy of Sciences of the United States of America·T F BumolN O Kaplan
Nov 1, 1983·Proceedings of the National Academy of Sciences of the United States of America·H P Vollmers, W Birchmeier
Dec 1, 1983·Proceedings of the National Academy of Sciences of the United States of America·P M CaponeT M Chu
Dec 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·J A DrebinM I Greene
Mar 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·U D Staerz, M J Bevan
Nov 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·J Nikolić-Zugić, M J Bevan
Jul 1, 1986·International Reviews of Immunology·F K Stevenson, G T Stevenson
May 1, 1989·International Reviews of Immunology·H G Rammensee
Jun 18, 2015·Expert Opinion on Drug Discovery·Piotr Smolewski, Tadeusz Robak
Aug 28, 2012·Advanced Drug Delivery Reviews·Sotirios Koutsopoulos
Feb 18, 2014·Clinical and Translational Science·Andrew M HarrisonAnthony J Windebank
Feb 1, 1981·Analytical Biochemistry·G S Eisenbarth
Oct 1, 1989·Journal of Clinical Pharmacology·V V Ranade
Dec 1, 1983·Journal of Cutaneous Pathology·A Estabrook, J A Patterson
Jan 1, 1981·American Journal of Reproductive Immunology : AJRI·M B ZaleskiJ Reichner
Dec 15, 1988·International Journal of Cancer. Journal International Du Cancer·L N LarsonJ Holmgren
Jul 15, 1988·International Journal of Cancer. Journal International Du Cancer·D BerendsN J de Both
Dec 1, 1981·European Journal of Immunology·M MichaelidesI F McKenzie
Jan 1, 1982·Immunological Reviews·F K JansenG A Voisin
Nov 1, 1981·The Journal of Pediatrics·S E SallanD G Nathan
Jan 1, 1984·Critical Reviews in Oncology/hematology·R O Dillman
Mar 15, 1984·Biochemical Pharmacology·I S TrowbridgeC Sauvage

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antibody Specificity

Antibodies produced by B cells are highly specific for antigen as a result of random gene recombination and somatic hypermutation and affinity maturation. As the main effector of the humoral immune system, antibodies can neutralize foreign cells. Find the latest research on antibody specificity here.